Hematology NewsAntibody face-off in follicular lymphoma gives PFS, but not OS, edge to obinutuzumabDecember 5, 2016Indolent LymphomaLymphoma & Plasma Cell DisordersMantle Cell LymphomaFollicular Lymphoma
Hematology NewsIbrutinib bodes well for relapsed mantle-cell lymphomaMarch 2, 2016Mantle Cell LymphomaLymphoma & Plasma Cell DisordersMelanoma
Oncology PracticeKi-67 bests cytology, growth pattern as prognostic factor for MCLFebruary 29, 2016Lymphoma & Plasma Cell DisordersMantle Cell Lymphoma
Hematology NewsLenalidomide plus rituximab achieves 87% response rateNovember 4, 2015Mantle Cell LymphomaLymphoma & Plasma Cell DisordersMelanoma
Hematology NewsRBAC500 safe, effective for elderly patients with mantle cell lymphomaJuly 8, 2015Mantle Cell LymphomaLymphoma & Plasma Cell DisordersRare Diseases
Hematology NewsBendamustine regimen may be induction-therapy option in mantle cell lymphomaJuly 8, 2015Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsSwapping bortezomib for vincristine improves PFS in mantle cell lymphomaJune 10, 2014Mantle Cell LymphomaTransfusion Medicine
Hematology News'Highest response rate ever reported' in relapsed mantle cell lymphomaDecember 13, 2012Mantle Cell Lymphoma
Hematology NewsCNS Events Not Immediately Fatal in Mantle Cell LymphomasJune 29, 2012Neuro-oncologyMantle Cell Lymphoma
